The peripheral blood levels of proinflammatory TH17 cells and IL17 plasma levels are also suggested increased in untreated AML, but in contrast to TREG cells these levels normalize when complete remission is achieved [11]. The gene discussed is IL17A; the disease is acute myeloid leukemia.